FTFinancial Times·4hBusiness
score+0.60
Dassault Systèmes in talks to buy drug trial software company for about $2bn
Original
Dassault Systèmes in talks to buy drug trial software company for about $2bn
“Acquisition framed constructively as strategic growth and market expansion into life sciences with concrete investment figures.”